MedTrace Logo

The Effect of Model-Based PMR Training on Anxiety and Blood Sugar Levels to Women With Gestational Diabetes

NCT05611541 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2022-11-10

No results posted yet for this study

Summary

This research is a randomized controlled experimental study to evaluate the effects of PMR application based on HBM in terms of blood sugar and anxiety levels in women with GDM. 34 pregnant women who applied PMR formed the "intervention group" and 34 pregnant women who did not practice PMR formed the "control group". The intervention group received "Progressive Muscle Relaxation Training". It was determined that there was a statistically significant difference between the last follow-up state anxiety score averages, and the intermediate and final follow-up trait anxiety scores between the intervention and control groups. It was determined that PMR provided a decrease in psychological anxiety levels in pregnant women with GDM, and did not have a positive effect on physiologically fasting, 1 hour postprandial and 2 hour postprandial blood glucose levels. PMR training prepared based on HBM is a method that nurses can perform independently to ensure the psychological well-being of pregnant women with GDM.

Conditions

  • Gestational Diabetes Mellitus in Pregnancy
  • Anxiety in Pregnancy

Interventions

BEHAVIORAL

Diet therapy, Progressive Muscle Relaxation training, Progressive Muscle Relaxation group

The group that received Progressive Muscle Relaxation training and applied progressive muscle relaxation for 8 weeks.

BEHAVIORAL

The group who received diet therapy and practiced their daily activities.

The group who received diet therapy and practiced their daily activities.

Sponsors & Collaborators

  • Ege University

    lead OTHER

Principal Investigators

  • Nilüfer Tok Yanık · Ege Üniversitesi Hemşirelik Fakültesi

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2020-10-30
Completion
2021-09-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05611541 on ClinicalTrials.gov